Citations 1
Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
DuBois, Steven G. , Marachelian, Araz , Fox, Elizabeth , Kudgus, Rachel A. , Groshen, Susan , Malvar, Jemily , Wagner, Lars M. , Hawkins, Randall A., Lai, Hollie , Boucher, Najee, Czarnecki, Scarlett, Mossé, Yaël P. , Reid, Joel M. , Bagatell, Rochelle , Maris, John M. , Courtier, Jesse , Goodarzian, Fariba , Shimada, Hiroyuki , Tsao-Wei, Denice D , Matthay, Katherine K.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10556-10556
